Her primary areas of investigation include Internal medicine, Endocrinology, Breast cancer, Ovarian cancer and Prospective cohort study. Her work in Internal medicine addresses subjects such as Oncology, which are connected to disciplines such as Adenocarcinoma. Many of her studies on Endocrinology apply to Physiology as well.
Her study in Breast cancer is interdisciplinary in nature, drawing from both Sex hormone-binding globulin and Prolactin. Her work deals with themes such as Rate ratio, Gynecology, Serous fluid and Genome-wide association study, which intersect with Ovarian cancer. Her Prospective cohort study research includes themes of Epidemiology, Incidence, Cohort study, Case-control study and Disease.
Her primary areas of study are Internal medicine, Ovarian cancer, Oncology, Prospective cohort study and Endocrinology. Her study in Internal medicine concentrates on Cancer, Breast cancer, Case-control study, Odds ratio and Body mass index. The various areas that Shelley S. Tworoger examines in her Breast cancer study include Quartile, Nested case-control study and Physiology.
Her Ovarian cancer study combines topics from a wide range of disciplines, such as Epidemiology, Serous fluid, Confidence interval, Gynecology and Proportional hazards model. Her research investigates the link between Oncology and topics such as Single-nucleotide polymorphism that cross with problems in Cancer research. The Prospective cohort study study combines topics in areas such as Incidence, Cohort study, Cohort and Risk factor.
Shelley S. Tworoger focuses on Internal medicine, Ovarian cancer, Oncology, Prospective cohort study and Hazard ratio. Her study in Odds ratio, Cancer, Body mass index, Disease and Nurses' Health Study is done as part of Internal medicine. Shelley S. Tworoger combines subjects such as Endocrinology and Type 2 diabetes with her study of Disease.
Shelley S. Tworoger has included themes like Cohort study, Serous fluid, Confidence interval, Carcinoma and Cohort in her Ovarian cancer study. Her research in Oncology intersects with topics in Inflammation, Case-control study, Biomarker, Breast cancer and Risk factor. The study incorporates disciplines such as Lower risk, Ovarian tumor and Endometrial cancer in addition to Prospective cohort study.
Shelley S. Tworoger mostly deals with Internal medicine, Ovarian cancer, Oncology, Hazard ratio and Proportional hazards model. Her research is interdisciplinary, bridging the disciplines of Type 2 diabetes and Internal medicine. She has researched Ovarian cancer in several fields, including Cohort study, Lower risk, Serous fluid, Aspirin and Cohort.
Her Oncology research incorporates themes from Inflammation, Biomarker, Breast cancer, Cancer prevention and Risk factor. Her Hazard ratio study incorporates themes from Body mass index, Nurses' Health Study, Obstructive sleep apnea and Obstetrics. Her Prospective cohort study research is multidisciplinary, relying on both Psychological intervention and Marital status.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension
John P. Forman;Edward Giovannucci;Michelle D. Holmes;Heike A. Bischoff-Ferrari.
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
Ganna Chornokur;Hui-Yi Lin;Jonathan P. Tyrer;Kate Lawrenson.
PLOS ONE (2015)
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley.
Nature Genetics (2013)
Endogenous Steroid Hormone Concentrations and Risk of Breast Cancer Among Premenopausal Women
A. Heather Eliassen;Stacey A. Missmer;Shelley S. Tworoger;Donna Spiegelman.
Journal of the National Cancer Institute (2006)
Effect of Exercise on Serum Estrogens in Postmenopausal Women A 12-Month Randomized Clinical Trial
Anne McTiernan;Anne McTiernan;Shelley S. Tworoger;Shelley S. Tworoger;Cornelia M. Ulrich;Yutaka Yasui.
Cancer Research (2004)
Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development
Jared R Mayers;Chen Wu;Chen Wu;Clary B Clish;Peter Kraft.
Nature Medicine (2014)
Circulating sex hormones and breast cancer risk factors in postmenopausal women: Reanalysis of 13 studies
T J Key;P N Appleby;G K Reeves;A W Roddam;A W Roddam.
British Journal of Cancer (2011)
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
Paul D.P. Pharoah;Ya Yu Tsai;Susan J. Ramus;Catherine M. Phelan.
Nature Genetics (2013)
Plasma adiponectin concentrations and risk of incident breast cancer.
Shelley S. Tworoger;Shelley S. Tworoger;A. Heather Eliassen;A. Heather Eliassen;Theodoros Kelesidis;Graham A. Colditz;Graham A. Colditz.
The Journal of Clinical Endocrinology and Metabolism (2007)
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.
Honglin Song;Susan J. Ramus;Jonathan Tyrer;Kelly L. Bolton;Kelly L. Bolton.
Nature Genetics (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: